ARCHIVES

Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials.

This article is from The Cancer Letter archive.

Vol. 30 No. 39 | October 15, 2004

Download PDF Visit The Full Archive

Related Articles

Former Group Chair Responds To Niederhuber: Change But Don’t Dissolve Cooperative Groups

July 2, 2010

NCI May Rent Chimps to Test AIDS Vaccines

November 29, 1985

Tests Find No Conclusive Evidence On Two Chemicals

September 21, 1979

Rauscher Summarizes Criticism of Cooperative Groups; Changes To Await May 22024 Conference

May 9, 1975

Rimer, Boxer Reappointed to NCAB; 4 Others Named

June 28, 1996

NCI Study Tests Donor T Cells Against Breast Cancer

August 29, 2003